Prevention of Recurrence in Depression With Drugs and CT — CPT3  

Depression Clinical Trial

Official title: Prevention of Recurrence in Depression With Drugs and CT

Status Completed

Clinical Trial Summary

This study will determine whether the addition of Cognitive Therapy (CT) to antidepressant medication (ADM) enhances treatment for depression. This study will also test whether the addition of CT to ADM will prevent recurrences of depression after therapy is over.

Clinical Trial Description

It is commonly believed that the combination of ADM and psychotherapy is more effective in treating depression than either treatment alone. Data indicate that CT enhances the initial effects of ADM, but little research has been conducted to determine whether prior exposure to CT prevents the onset of new depressive episodes. This study will determine the effectiveness of adding CT to ADM for the treatment of depression.

Participants are randomly assigned to receive either ADM alone or ADM plus CT for up to 18 months. Remitted patients are continued on medication for up to 36 months from the point of initial randomization until they meet criteria for recovery. At recovery, patients receiving combined treatment discontinue cognitive therapy; all recovered patients are randomized a second time to either maintenance medication or medication withdrawal. Patients are then monitored over 36 months to ascertain risk for recurrence of depressive symptoms. ;

Related Conditions & MeSH terms

• Depression
• Depressive Disorder
• Recurrence

• NCT number: NCT00057577
• Study type: Interventional
• Source: Vanderbilt University
• Status: Completed
• Phase: Phase 4
• Start date: October 2002
• Completion date: March 2014